Australian Researchers Test Reprogramming Adult Stem Cells
This article was originally published in PharmAsia News
Australian researchers say they have succeeded in testing human stem cells without an egg, a technique designed to avoid the controversy of using human embryos for research. The work is the first successful test of the technique outside Japan or the United States. Monash University's Australian Stem Cell Centre obtained U.S. adult cells to reprogram to make them behave more like embryonic stem cells as a new way of obtaining induced pluripotent stem cells. (Click here for more
You may also be interested in...
First quarter submission volume is the second lowest of the GDUFA era, in part because of BE study problems caused by the pandemic.
The Centers for Medicare and Medicaid Services has agreed to provide national Medicare coverage for mitral valve transcatheter edge-to-edge repair under a new coverage with evidence development policy. See what Neil Moat, chief medical officer for Abbott’s structural heart business, said about it here.
South Korea’s Ministry of Food and Drug Safety and Taiwan’s Food and Drug Administration will transition from ICCR observers to full members, joining regulatory authorities from the US, Europe, Japan, Canada and Brazil. PCPC’s Francine Lamoriello, EVP of global affairs, discusses.